1.	Phase III Placebo-Controlled Study of Soy Phytoestrogens in the Management of Hot Flashes in Women with a History of Breast Cancer (Summary Last Modified 08/98) Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-969258, NCI-P97-0126
2.	Phase III Randomized Study of Isoflavones in Reducing Risk Factors in Patients With Stage I or II Prostate Cancer Phase: Phase III Type: Prevention Status: Completed Age: 50 to 80 Sponsor: NCI Protocol IDs: MCC-0002, NCI-4031, NCI-P01-0195, NCT00027950
3.	Role of Soy Supplementation in Prostate Cancer Development Phase: Phase III Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CLIN-006-05S, NCT00255125
4.	Phase III Randomized Study of Soy Protein/Isoflavones and Venlafaxine on Vasomotor Symptoms in Patients With Prostate Cancer Undergoing Hormonal Manipulation Phase: Phase III Type: Supportive care Status: Closed Age: 21 and over Sponsor: NCI Protocol IDs: CCCWFU-97405, CCCWFU 97405, WFU-97405, CCCWFU-BG05-529, NCT00354432
5.	Phase III Randomized Study of the Effects of Dietary Soy on Estrogens in Breast Fluid, Serum, and Urine Samples From Healthy Women Phase: Phase III Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 30 to 45 Sponsor: NCI Protocol IDs: UHM-CHS-4116, CHS 14116, NCT00513916
6.	Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000353197, P30CA022453, WSU-C-2418, NCT00078923
7.	Soy Isoflavones and Breast Cancer Risk Reduction Phase: Phase II Type: Prevention Status: Closed Age: 30 to 42 Sponsor: NCI, Other Protocol IDs: 03-260, UTMB GCRC #635, R01CA095545, M01RR000073, 1UL1RR029876-01, NCT00204490
8.	Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000466317, CCCWFU-98203, CCCWFU-BG03-332, NCT00345813
9.	Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 9639, NCT00594620
10.	The Specific Role of Isoflavones in Reducing Prostate Cancer Risk Phase: Phase II Type: Treatment Status: Completed Age: 50 to 80 Sponsor: Other Protocol IDs: MCC-12835, NCI #4031, CA 81920, NCT00617617
11.	Study of Metabolic Fate and Plasma Kinetics of Dietary Soy Isoflavones (Summary Last Modified 06/2000) Phase: No phase specified Type: Prevention Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UCMC-CHMC-91-5-3, NCI-P97-0117, NCT00003100
12.	Randomized Pilot Study of Isoflavones Versus Lycopene Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 45 to 80 Sponsor: NCI Protocol IDs: MCC-0105, NCI-3811, NCI-P02-0216, HLMCC 0105, NCT00042731
13.	Pilot Study of Soy-Based Meal Replacement (Almased®) as a Weight Loss Intervention in Patients With Estrogen Receptor/Progesterone Receptor-Negative Stage I-III Breast Cancer in Complete Remission Phase: No phase specified Type: Behavioral study, Educational/Counseling/Training, Supportive care Status: Closed Age: 21 and over Sponsor: NCI Protocol IDs: CCCWFU-98904, NCT00343434
14.	Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance Phase: No phase specified Type: Treatment Status: Closed Age: 45 and over Sponsor: Other Protocol IDs: PROS0022, 97408, NCT00482157
15.	Soy, Selenium and Breast Cancer Risk Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Completed Age: 35 to 50 Sponsor: Other Protocol IDs: R14697, 07/Q0101/10, NCT00555386